rhEGF

DRUG4 trials

Sponsors

Daewoong Pharmaceutical Co. LTD., SVS Institute of Dental Sciences, PT. Daewoong Infion, Center for Genetic Engineering and Biotechnology (CIGB), Havana.

Conditions

Diabetic foot ulcer, Wagner grades 1 or 2PeriodontitisSkin Graft ScarSplit-Thickness Skin Graft (STSG)Stomatitis

Phase 1

Pharmacokinetics of intralesional EGF in patients with diabetic foot ulcers.

Active, not recruitingRPCEC00000047

Center for Genetic Engineering and Biotechnology (CIGB), Havana.Diabetic foot ulcer, Wagner grades 1 or 2

Start: 2007-11-19Target: 16Updated: 2026-03-30

RhEGF Incorporated in An Absorbable Collagen Membrane for The Management Of Gingival Recession Defects

SVS Institute of Dental SciencesPeriodontitis

Start: 2019-10-01End: 2021-11-30Target: 30Updated: 2020-05-05

Phase 3

The Clinical Study for Evaluation of Efficacy and Safety of EGF on Oral Mucositis in Radiation Therapy Patients

Daewoong Pharmaceutical Co. LTD.Stomatitis

Start: 2010-03-31End: 2015-12-31Target: 300Updated: 2014-08-04

Unknown Phase

Efficacy and Safety Evaluation of EASYEF® in Acute Wound (Split-thickness Skin Graft Donor Site)

CompletedNCT05335720

PT. Daewoong InfionSkin Graft Scar, Split-Thickness Skin Graft (STSG)

Start: 2019-07-19End: 2020-04-08Updated: 2022-07-22